Advertisement

Index by author

June 01, 1991; Volume 39,Issue 6

A

  1. Arvidsson, L E

    1. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

B

  1. Baba, M

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

  2. Baird, J G

    1. Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
      J G Baird, R A Challiss and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 745-753;

  3. Balzarini, J

    1. Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
      M Cools, J Balzarini and E De Clercq
      Molecular Pharmacology June 1991, 39 (6) 718-724;

C

  1. Catt, K J

    1. Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;

  2. Challiss, R A

    1. Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
      J G Baird, R A Challiss and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 745-753;

  3. Chatterjee, T K

    1. Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
      T K Chatterjee and R A Fisher
      Molecular Pharmacology June 1991, 39 (6) 798-804;

  4. Clark, R B

    1. Potent Gi-mediated inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate.
      M A Proll and R B Clark
      Molecular Pharmacology June 1991, 39 (6) 740-744;

  5. Cooke, A M

    1. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

  6. Cools, M

    1. Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
      M Cools, J Balzarini and E De Clercq
      Molecular Pharmacology June 1991, 39 (6) 718-724;

  7. Cornfield, L J

    1. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

  8. Costa, E

    1. Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;

  9. Cox, B A

    1. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;

D

  1. De Clercq, E

    1. Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
      M Cools, J Balzarini and E De Clercq
      Molecular Pharmacology June 1991, 39 (6) 718-724;
    2. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
    3. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

F

  1. Fisher, R A

    1. Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
      T K Chatterjee and R A Fisher
      Molecular Pharmacology June 1991, 39 (6) 798-804;

G

  1. Gunji, H

    1. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;

H

  1. Hacksell, U

    1. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

  2. Hammond, J R

    1. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
      J R Hammond
      Molecular Pharmacology June 1991, 39 (6) 771-779;

  3. Henningsen, R A

    1. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;

  4. Hwang, S B

    1. Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
      S B Hwang and S Wang
      Molecular Pharmacology June 1991, 39 (6) 788-797;

I

  1. Iida, T

    1. Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;

J

  1. Jansen, R W

    1. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

K

  1. Kato, R

    1. Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;

  2. Kharbanda, S

    1. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;

  3. Kufe, D

    1. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;

L

  1. Lambert, G

    1. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

M

  1. Maksay, G

    1. Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
      G Maksay, Z Tegyey and M Simonyi
      Molecular Pharmacology June 1991, 39 (6) 725-732;

  2. McBain, J

    1. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

  3. Meijer, D K

    1. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

  4. Mellin, C

    1. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

  5. Merelli, F

    1. Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;

  6. Molema, G

    1. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

  7. Mori, S

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

  8. Murayama, N

    1. Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;

N

  1. Nahorski, S R

    1. Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
      J G Baird, R A Challiss and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 745-753;
    2. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

  2. Nelson, D L

    1. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

  3. Neve, K A

    1. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;

  4. Neve, R L

    1. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;

  5. Nitta, I

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

O

  1. O'Donnell, J K

    1. Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
      J K O'Donnell, R W Sweet and J M Stadel
      Molecular Pharmacology June 1991, 39 (6) 702-710;

P

  1. Pauwels, R

    1. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

  2. Potter, B V

    1. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

  3. Proll, M A

    1. Potent Gi-mediated inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate.
      M A Proll and R B Clark
      Molecular Pharmacology June 1991, 39 (6) 740-744;

  4. Puia, G

    1. Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;

R

  1. Rubin, E

    1. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;

S

  1. Safrany, S T

    1. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

  2. Scammell, J G

    1. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;

  3. Schols, D

    1. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

  4. Seeburg, P H

    1. Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;

  5. Sekiya, K

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

  6. Shimada, M

    1. Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;

  7. Simonyi, M

    1. Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
      G Maksay, Z Tegyey and M Simonyi
      Molecular Pharmacology June 1991, 39 (6) 725-732;

  8. Spanoyannis, A

    1. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;

  9. Stadel, J M

    1. Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
      J K O'Donnell, R W Sweet and J M Stadel
      Molecular Pharmacology June 1991, 39 (6) 702-710;

  10. Stojilković, S S

    1. Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;

  11. Strada, S J

    1. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;

  12. Strupish, J

    1. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

  13. Sweet, R W

    1. Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
      J K O'Donnell, R W Sweet and J M Stadel
      Molecular Pharmacology June 1991, 39 (6) 702-710;

T

  1. Takashima, H

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

  2. Tanaka, H

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

  3. Tegyey, Z

    1. Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
      G Maksay, Z Tegyey and M Simonyi
      Molecular Pharmacology June 1991, 39 (6) 725-732;

  4. Thompson, W J

    1. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;

U

  1. Ubasawa, M

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

  2. Umezu, K

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

V

  1. Vallgårda, J

    1. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

  2. Vicini, S

    1. Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;

W

  1. Walker, R T

    1. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

  2. Wang, S

    1. Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
      S B Hwang and S Wang
      Molecular Pharmacology June 1991, 39 (6) 788-797;

  3. Whalin, M E

    1. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;

  4. Wojcikiewicz, R J

    1. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

Y

  1. Yamazoe, Y

    1. Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;
Back to top

In this issue

Advertisement